Literature DB >> 35875308

Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing.

Maleeha Saleem1, Karan Pahuja1, Tehreem Fatima1, Steven Hamilton2, Christina Wjasow3, Justin Fox4.   

Abstract

Implantable cardioverter defibrillators (ICD) are used for the primary and secondary prevention of sudden cardiac death (SCD). Currently, two different modalities of ICDs are in use: transvenous (TV) and subcutaneous (S-ICD). The use of S-ICDs has been driven by several potential benefits of this technology: preservation of central venous vasculature, no risk of vascular or myocardial injury during implant, easier explanation, and lower risk of systemic infections. Inappropriate shocks are defined as shocks delivered for non-life-threatening arrhythmias or because of oversensing. Here, we present a case of a 58-year-old man who began experiencing inappropriate shocks three years after S-ICD placement. Careful analysis of the ICD showed T wave oversensing with no malfunction of the device. The shocks persisted even after reprogramming, leading to subsequent ICD removal and loop recorder implantation. The onset of shock episodes coincided with the improvement of left ventricular ejection fraction (LVEF). To the best of our knowledge, this is the first published report of cardiac remodeling leading to uncorrectable T wave oversensing that subsequently required S-ICD explant. This represents a potentially important limitation of S-ICD technology, especially as S-ICD use rises and medical therapy for cardiomyopathy continues to improve.
Copyright © 2022, Saleem et al.

Entities:  

Keywords:  anti tachycardia pacing; non ischemic cardiomyopathy; overdrive pacing; subcutaneous implantable cardioverter defibrillators; ventricular fibrillation

Year:  2022        PMID: 35875308      PMCID: PMC9299751          DOI: 10.7759/cureus.26129

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Authors:  Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

2.  Standby automatic defibrillator. An approach to prevention of sudden coronary death.

Authors:  M Mirowski; M M Mower; W S Staewen; B Tabatznik; A I Mendeloff
Journal:  Arch Intern Med       Date:  1970-07

Review 3.  Defibrillators: Selecting the Right Device for the Right Patient.

Authors:  Sana M Al-Khatib; Paul Friedman; Kenneth A Ellenbogen
Journal:  Circulation       Date:  2016-11-01       Impact factor: 29.690

Review 4.  Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.

Authors:  Ryan T Borne; Paul D Varosy; Frederick A Masoudi
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

5.  Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II.

Authors:  Emily P Zeitler; Sana M Al-Khatib; Daniel J Friedman; Joo Yoon Han; Jeanne E Poole; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Arthur J Moss; Kerry L Lee; Paul Dorian; Riccardo Cappato; Alan H Kadish; Peter J Kudenchuk; Daniel B Mark; Lurdes Y T Inoue; Gillian D Sanders
Journal:  J Cardiovasc Electrophysiol       Date:  2017-08-23

6.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

7.  T wave oversensing.

Authors:  Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

8.  Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.

Authors:  Eiichi Watanabe; Katsunori Okajima; Akira Shimane; Tomoya Ozawa; Tetsuyuki Manaka; Itsuro Morishima; Toru Asai; Masahiko Takagi; Toshihiro Honda; Atsunobu Kasai; Eitaro Fujii; Kohei Yamashiro; Ritsuko Kohno; Haruhiko Abe; Takashi Noda; Takashi Kurita; Shigeyuki Watanabe; Hiroya Ohmori; Takashi Nitta; Yoshifusa Aizawa; Ken Kiyono; Ken Okumura
Journal:  J Interv Card Electrophysiol       Date:  2017-07-20       Impact factor: 1.900

9.  Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator.

Authors:  Sana M Al-Khatib; Sasmrita Belbase; Diane Sauro; Gail Brock; Kathleen Brink; Kevin P Jackson
Journal:  HeartRhythm Case Rep       Date:  2016-08-17

10.  Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.

Authors:  Michael R Gold; Pier D Lambiase; Mikhael F El-Chami; Reinoud E Knops; Johan D Aasbo; Maria Grazia Bongiorni; Andrea M Russo; Jean-Claude Deharo; Martin C Burke; Jay Dinerman; Craig S Barr; Naushad Shaik; Nathan Carter; Thomas Stoltz; Kenneth M Stein; Amy J Brisben; Lucas V A Boersma
Journal:  Circulation       Date:  2020-10-19       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.